Stryker's $400M CMR Option; Germany Nvidia Physical AI Pact
Stryker will invest roughly $400 million in CMR Surgical, securing exclusive U.S. sales rights to the Versius robot and an exclusive option to acquire the remainder. The structure places the deal among the largest medtech robotics transactions in recent years. It also stages the integration risk: Stryker locks the commercial channel first, then decides on full ownership.
Germany plans a large-scale AI partnership with Nvidia involving about 12 companies, including Siemens and Audi, aimed at building a physical AI foundation and training international talent. Compared with single-firm product launches, national coordination places compute, manufacturing and talent supply in one framework. On that basis, the unit of competition in physical AI is shifting from companies to industrial coalitions.
The binding constraint on humanoid economics is duty cycle. Agility is working with Nyobolt on an ultra-fast charging battery for Digit 5, claiming 9 minutes of charge supports 90 minutes of work and more than 20 hours of operation per day; Coca-Cola Europacific Partners is scaling Boston Dynamics' Spot globally after a Barcelona deployment. Procurement attention is moving from peak capability to available working hours.
Data and talent layers are tightening in parallel. Hesai launched Kosmo, a 3D world data engine for physical AI combining an 8K spatial camera with a platform; Tencent has recruited a key developer from a robot operating system team. Sanctuary AI published a dexterity gradient, mapping grippers and high-DOF hands to distinct task tiers, which gives buyers a workable way to match cost against capability.
Unitree's Wang Xingxing put an embodied AI tipping point within one to two years, while the Robot ETF (159213) drew over 12 million yuan of net inflows despite a 3% decline. Two things to watch: whether option-structured deals like Stryker's become a template, and whether duty-cycle metrics enter formal procurement specifications, which would reorder R&D priorities at robot makers.